ASX - By Stock
|
PAR |
Re:
Ann: Trading Halt
|
|
Zenox
|
276 |
106K |
5 |
14/08/22 |
14/08/22 |
ASX - By Stock
|
276
|
106K
|
5
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Trading Halt
|
|
Zenox
|
276 |
106K |
7 |
11/08/22 |
11/08/22 |
ASX - By Stock
|
276
|
106K
|
7
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Trading Halt
|
|
Zenox
|
276 |
106K |
3 |
11/08/22 |
11/08/22 |
ASX - By Stock
|
276
|
106K
|
3
|
|
ASX - By Stock
|
PAR |
Re:
WTF- what's with the share price movement
|
|
Zenox
|
129 |
59K |
9 |
10/08/22 |
10/08/22 |
ASX - By Stock
|
129
|
59K
|
9
|
|
ASX - By Stock
|
PAR |
Re:
WTF- what's with the share price movement
|
|
Zenox
|
129 |
59K |
19 |
09/08/22 |
09/08/22 |
ASX - By Stock
|
129
|
59K
|
19
|
|
ASX - By Stock
|
PAR |
Re:
Paradigm on the television .
|
|
Zenox
|
63 |
26K |
3 |
09/08/22 |
09/08/22 |
ASX - By Stock
|
63
|
26K
|
3
|
|
ASX - By Stock
|
PAR |
Re:
Chart
|
|
Zenox
|
4.2K |
3.8M |
22 |
08/08/22 |
08/08/22 |
ASX - By Stock
|
4.2K
|
3.8M
|
22
|
|
ASX - By Stock
|
PAR |
Re:
Chart
|
|
Zenox
|
4.2K |
3.8M |
10 |
02/08/22 |
02/08/22 |
ASX - By Stock
|
4.2K
|
3.8M
|
10
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Paradigm Partners with NFL Alumni Health for OA Program
|
|
Zenox
|
63 |
20K |
7 |
27/07/22 |
27/07/22 |
ASX - By Stock
|
63
|
20K
|
7
|
|
ASX - By Stock
|
PAR |
Re:
Chart
|
|
Zenox
|
4.2K |
3.8M |
0 |
22/07/22 |
22/07/22 |
ASX - By Stock
|
4.2K
|
3.8M
|
0
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Investor Webinar
|
|
Zenox
|
103 |
44K |
8 |
21/07/22 |
21/07/22 |
ASX - By Stock
|
103
|
44K
|
8
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Investor Webinar
|
|
Zenox
|
103 |
44K |
15 |
21/07/22 |
21/07/22 |
ASX - By Stock
|
103
|
44K
|
15
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Application for quotation of securities - PAR
|
|
Zenox
|
27 |
8.6K |
0 |
14/07/22 |
14/07/22 |
ASX - By Stock
|
27
|
8.6K
|
0
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Application for quotation of securities - PAR
|
|
Zenox
|
27 |
8.6K |
3 |
14/07/22 |
14/07/22 |
ASX - By Stock
|
27
|
8.6K
|
3
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Paradigm Partners with NFL Alumni Health for OA Program
|
|
Zenox
|
63 |
20K |
16 |
13/07/22 |
13/07/22 |
ASX - By Stock
|
63
|
20K
|
16
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Paradigm Partners with NFL Alumni Health for OA Program
|
|
Zenox
|
63 |
20K |
23 |
13/07/22 |
13/07/22 |
ASX - By Stock
|
63
|
20K
|
23
|
|
ASX - By Stock
|
PAR |
Re:
PAR on Bell Potter list of stocks for FY 23
|
|
Zenox
|
23 |
10K |
9 |
08/07/22 |
08/07/22 |
ASX - By Stock
|
23
|
10K
|
9
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Paradigm reports global progress in phase 3 study
|
|
Zenox
|
21 |
8.4K |
22 |
06/07/22 |
06/07/22 |
ASX - By Stock
|
21
|
8.4K
|
22
|
|
ASX - By Stock
|
PAR |
Re:
research reports and media
|
|
Zenox
|
4.1K |
1.9M |
2 |
05/07/22 |
05/07/22 |
ASX - By Stock
|
4.1K
|
1.9M
|
2
|
|
ASX - By Stock
|
PAR |
Re:
research reports and media
|
|
Zenox
|
4.1K |
1.9M |
10 |
05/07/22 |
05/07/22 |
ASX - By Stock
|
4.1K
|
1.9M
|
10
|
|
ASX - By Stock
|
PAR |
Re:
Chart
|
|
Zenox
|
4.2K |
3.8M |
2 |
05/07/22 |
05/07/22 |
ASX - By Stock
|
4.2K
|
3.8M
|
2
|
|
ASX - By Stock
|
PAR |
Re:
research reports and media
|
|
Zenox
|
4.1K |
1.9M |
2 |
04/07/22 |
04/07/22 |
ASX - By Stock
|
4.1K
|
1.9M
|
2
|
|
ASX - By Stock
|
PAR |
Re:
research reports and media
|
|
Zenox
|
4.1K |
1.9M |
2 |
04/07/22 |
04/07/22 |
ASX - By Stock
|
4.1K
|
1.9M
|
2
|
|
ASX - By Stock
|
PAR |
Re:
Ann: 100% Recruitment in Synovial Fluid Biomarker Trial
|
|
Zenox
|
24 |
10K |
7 |
03/07/22 |
03/07/22 |
ASX - By Stock
|
24
|
10K
|
7
|
|
ASX - By Stock
|
PAR |
Re:
Ann: 100% Recruitment in Synovial Fluid Biomarker Trial
|
|
Zenox
|
24 |
10K |
6 |
01/07/22 |
01/07/22 |
ASX - By Stock
|
24
|
10K
|
6
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Paradigm Reports Australian Patent Acceptance
|
|
Zenox
|
64 |
24K |
0 |
01/07/22 |
01/07/22 |
ASX - By Stock
|
64
|
24K
|
0
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Paradigm Reports Australian Patent Acceptance
|
|
Zenox
|
64 |
24K |
8 |
30/06/22 |
30/06/22 |
ASX - By Stock
|
64
|
24K
|
8
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Paradigm Reports Australian Patent Acceptance
|
|
Zenox
|
64 |
24K |
4 |
30/06/22 |
30/06/22 |
ASX - By Stock
|
64
|
24K
|
4
|
|
ASX - By Stock
|
PAR |
Re:
Back to the Future
|
|
Zenox
|
21 |
9.8K |
1 |
29/06/22 |
29/06/22 |
ASX - By Stock
|
21
|
9.8K
|
1
|
|
ASX - By Stock
|
PAR |
Re:
Back to the Future
|
|
Zenox
|
21 |
9.8K |
2 |
28/06/22 |
28/06/22 |
ASX - By Stock
|
21
|
9.8K
|
2
|
|
ASX - By Stock
|
PAR |
Re:
Back to the Future
|
|
Zenox
|
21 |
9.8K |
20 |
27/06/22 |
27/06/22 |
ASX - By Stock
|
21
|
9.8K
|
20
|
|
ASX - By Stock
|
PAR |
Re:
research reports and media
|
|
Zenox
|
4.1K |
1.9M |
7 |
15/06/22 |
15/06/22 |
ASX - By Stock
|
4.1K
|
1.9M
|
7
|
|
ASX - By Stock
|
NOX |
Re:
Ann: Noxopharm Corporate Presentation
|
|
Zenox
|
18 |
10K |
3 |
07/06/22 |
07/06/22 |
ASX - By Stock
|
18
|
10K
|
3
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Paradigm Receives $8.2m R&D Tax Incentive Refund
|
|
Zenox
|
19 |
9.0K |
2 |
07/06/22 |
07/06/22 |
ASX - By Stock
|
19
|
9.0K
|
2
|
|
ASX - By Stock
|
NOX |
Re:
Ann: Noxopharm Corporate Presentation
|
|
Zenox
|
18 |
10K |
5 |
07/06/22 |
07/06/22 |
ASX - By Stock
|
18
|
10K
|
5
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Paradigm Receives $8.2m R&D Tax Incentive Refund
|
|
Zenox
|
19 |
9.0K |
22 |
07/06/22 |
07/06/22 |
ASX - By Stock
|
19
|
9.0K
|
22
|
|
ASX - By Stock
|
TYP |
Re:
Ann: Business Update
|
|
Zenox
|
42 |
17K |
5 |
06/06/22 |
06/06/22 |
ASX - By Stock
|
42
|
17K
|
5
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Paradigm Appoints Experienced US-Based CEO
|
|
Zenox
|
82 |
31K |
13 |
31/05/22 |
31/05/22 |
ASX - By Stock
|
82
|
31K
|
13
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Paradigm Appoints Experienced US-Based CEO
|
|
Zenox
|
82 |
31K |
28 |
31/05/22 |
31/05/22 |
ASX - By Stock
|
82
|
31K
|
28
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Paradigm Appoints Experienced US-Based CEO
|
|
Zenox
|
82 |
31K |
8 |
30/05/22 |
30/05/22 |
ASX - By Stock
|
82
|
31K
|
8
|
|
ASX - By Stock
|
APX |
Re:
Ann: Indicative and Non-Binding Proposal and Trading Update
|
|
Zenox
|
110 |
55K |
1 |
26/05/22 |
26/05/22 |
ASX - By Stock
|
110
|
55K
|
1
|
|
ASX - By Stock
|
APX |
Re:
Ann: Trading Halt
|
|
Zenox
|
130 |
60K |
4 |
26/05/22 |
26/05/22 |
ASX - By Stock
|
130
|
60K
|
4
|
|
ASX - By Stock
|
TLX |
Re:
My analysis and intrinsic value of TLX March 2022
|
|
Zenox
|
82 |
42K |
0 |
11/05/22 |
11/05/22 |
ASX - By Stock
|
82
|
42K
|
0
|
|
ASX - By Stock
|
PAR |
Re:
research reports and media
|
|
Zenox
|
4.1K |
1.9M |
5 |
05/05/22 |
05/05/22 |
ASX - By Stock
|
4.1K
|
1.9M
|
5
|
|
ASX - By Stock
|
PAR |
Re:
research reports and media
|
|
Zenox
|
4.1K |
1.9M |
7 |
04/05/22 |
04/05/22 |
ASX - By Stock
|
4.1K
|
1.9M
|
7
|
|
ASX - By Stock
|
PAR |
Re:
research reports and media
|
|
Zenox
|
4.1K |
1.9M |
8 |
04/05/22 |
04/05/22 |
ASX - By Stock
|
4.1K
|
1.9M
|
8
|
|
ASX - By Stock
|
PAR |
Re:
research reports and media
|
|
Zenox
|
4.1K |
1.9M |
3 |
04/05/22 |
04/05/22 |
ASX - By Stock
|
4.1K
|
1.9M
|
3
|
|
ASX - By Stock
|
PAR |
Re:
Ampio -v- Zilosul
|
|
Zenox
|
39 |
15K |
4 |
03/05/22 |
03/05/22 |
ASX - By Stock
|
39
|
15K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Zenox
|
190 |
62K |
6 |
03/05/22 |
03/05/22 |
ASX - By Stock
|
190
|
62K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Zenox
|
190 |
62K |
17 |
02/05/22 |
02/05/22 |
ASX - By Stock
|
190
|
62K
|
17
|
|